![](/img/cover-not-exists.png)
Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway
Zhang, Yongxiang, Hai, Jie, Cao, Meng, Zhang, Yongli, Pei, Sujuan, Wang, Junbo, Zhang, QingguiVolume:
17
Language:
english
Journal:
International Immunopharmacology
DOI:
10.1016/j.intimp.2013.08.019
Date:
November, 2013
File:
PDF, 1.65 MB
english, 2013